Literature DB >> 24719948

Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.

Rui Zhang, Lei-Bo Xu, Hong Zeng, Xian-Huan Yu, Jie Wang, Chao Liu.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) with bile duct tumor thrombi (BDTT) is a rare event. The Bmi1 gene has been reported to play important roles in cancer initiation and progression. In this study, the expression of Bmi1 in HCC with BDTT was investigated.
METHODOLOGY: The expression of Bmi1 was examined immunohistochemically in HCC patients with BDTT (B+ group), HCC patients with vascular invasion (V+ group) and combined hepatocellular carcinoma and cholangiocarcinoma (C+ group), respectively. Besides, the Bmi1 mRNA level was investigated by real time PCR in the fresh samples obtained from 13 cases in B+ group, 10 cases in V+ group, and 6 cases in C+ group, respectively.
RESULTS: Immunohistochemical staining for Bmi1 showed Bmi1 was highly expressed in the B+ group in comparison with the C+ group and the V+ group, respectively. The Bmi1 mRNA level by real time PCR also showed that it was significantly up-regulated in B+ group compared with those of C+ group and V+ group, respectively. However, there was no statistically significant difference in Bmi1 levels between the subjects with vascular invasion and the subjects without vascular invasion.
CONCLUSIONS: Bmi1 might play important roles in the development of BDTT in HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24719948

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Preoperative risk factors for the early failure of the Kasai portoenterostomy in patients with biliary atresia.

Authors:  Mauro Ariel Capparelli; Victor Hugo Ayarzabal; Esteban Tomas Halac; Horacio Alberto Questa; Maria Julia Minetto; Guillermo Cervio; Marcelo Eugenio Barrenechea
Journal:  Pediatr Surg Int       Date:  2021-05-31       Impact factor: 1.827

Review 2.  Role of liver stem cells in hepatocarcinogenesis.

Authors:  Lei-Bo Xu; Chao Liu
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

3.  Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.

Authors:  Wen-rui Wu; Hong Sun; Rui Zhang; Xian-huan Yu; Xiang-de Shi; Man-sheng Zhu; Hong Zeng; Li-xu Yan; Lei-bo Xu; Chao Liu
Journal:  Oncotarget       Date:  2016-04-05

4.  Dysregulation of Bmi1 promotes malignant transformation of hepatic progenitor cells.

Authors:  R Zhang; W R Wu; X D Shi; L B Xu; M S Zhu; H Zeng; C Liu
Journal:  Oncogenesis       Date:  2016-02-29       Impact factor: 7.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.